Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A 6 Month Safety Extension Study of MBGS205

ClinicalTrials.gov ID: NCT02908074

Public ClinicalTrials.gov record NCT02908074. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6 Month, Double-blind Safety Extension Study of MBGS205

Study identification

NCT ID
NCT02908074
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mereo BioPharma
Industry
Enrollment
143 participants

Conditions and interventions

Interventions

  • BGS649 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 14, 2016
Primary completion
Sep 7, 2018
Completion
Nov 20, 2018
Last update posted
May 17, 2023

2016 – 2018

United States locations

U.S. sites
37
U.S. states
17
U.S. cities
37
Facility City State ZIP Site status
Mereo Research Site Mobile Alabama
Mereo Research Site Chandler Arizona
Mereo Research Site Phoenix Arizona
Mereo Research Site Scottsdale Arizona
Mereo Research Site Anaheim California
Mereo Research Site Greenbrae California
Mereo Research Site Lincoln California
Mereo Research Site Los Angeles California
Mereo Research Site San Diego California
Mereo Research Site Bradenton Florida
Mereo Research Site DeLand Florida
Mereo Research Site Fort Myers Florida
Mereo Research Site Hialeah Florida
Mereo Research Site St. Petersburg Florida
Mereo Research Site Meridian Idaho
Mereo Research Site Evansville Indiana
Mereo Research Site Marrero Louisiana
Mereo Research Site Elkridge Maryland
Mereo Research Site Henderson Nevada
Mereo Research Site Las Vegas Nevada
Mereo Research Site Albany New York
Mereo Research Site Garden City New York
Mereo Research Site Great Neck New York
Mereo Research Site New York New York
Mereo Research Site Rochester New York
Mereo Research Site Charlotte North Carolina
Mereo Research Site Raleigh North Carolina
Mereo Research Site Winston-Salem North Carolina
Mereo Research Site Mt. Pleasant South Carolina
Mereo Research Site Nashville Tennessee
Mereo Research Site Dallas Texas
Mereo Research Site Fort Worth Texas
Mereo Research Site Pearland Texas
Mereo Research Site San Antonio Texas
Mereo Research Site West Jordan Utah
Mereo Research Site Norfolk Virginia
Mereo Research Site Kenosha Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02908074, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 17, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02908074 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →